Summary & Overview
HCPCS Level II J2370: Injection of Phenylephrine HCl, Up to 1 ml
HCPCS Level II code J2370 denotes the injection of phenylephrine hydrochloride, billed for quantities up to 1 milliliter. This code is used when a clinician administers phenylephrine as a pharmacologic agent for vasoconstriction or blood pressure support in acute or procedural settings. Nationally, accurate coding for injectable drugs affects reimbursement, inventory control, and clinical documentation workflows across hospital outpatient departments, emergency departments, ambulatory surgical centers, and clinic-based infusion or injection areas.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context and service settings, guidance on typical billing and service-line classification, and a summary of available benchmarking and policy considerations where applicable. The publication outlines common modifiers associated with injectable drug administration when data are available, notes gaps where input data are missing, and highlights areas that commonly affect claim adjudication such as unit reporting, site-of-service designation, and drug documentation. This summary is intended for billing managers, revenue cycle professionals, and clinical staff involved in documentation and claim submission for injectable medications.
Billing Code Overview
HCPCS Level II code J2370 describes an injection of phenylephrine hydrochloride, billed for volumes up to 1 ml. The service is a pharmacologic injection typically administered for vascular support or vasoconstriction in settings where phenylephrine is indicated.
Service Type: Drug administration – single injectable medication
Typical Site of Service: Hospital outpatient department, emergency department, ambulatory surgical center, or clinic-based injection area
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult presenting to an ambulatory surgery center or emergency department with acute nasal bleeding (epistaxis) or requiring vasoconstriction for a simple ophthalmic or ENT procedure. A clinician (ENT surgeon, emergency physician, or ophthalmologist) administers a topical or local intranasal or subconjunctival injection of phenylephrine hydrochloride, J2370 (injection, phenylephrine hcl, up to 1 ml), to achieve localized vasoconstriction. The clinical workflow includes patient assessment, informed consent for topical/local vasoconstrictor use, preparation of the medication, administration by an authorized provider or supervised practitioner, monitoring for cardiovascular response (blood pressure and heart rate), and documentation of dose, site, and patient response. Typical sites of service are outpatient clinic, emergency department, ambulatory surgery center, and physician office. Common patient presentations include anterior epistaxis refractory to topical sprays, preparation for nasal packing or cautery, minor nasal or ocular procedures requiring hemostasis, and intranasal preparation prior to nasogastric tube insertion in selected cases.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work required is substantially greater than typical for administration of a vasoconstrictive injection (rare). |